advertisements
26.02.2024
Expert*in Governance für Recruitingprozesse inkl. Vendormanagement (m/w/d)
Germany, Frankfurt Taunusanlage 12
... Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, ...
More »
0010 Deutsche Bank Aktiengesellschaft
13.07.2024
Maersk Trainee (UAE National)
Emiratos Árabes Unidos, AEDXB12 - Dubai - Burj Al Salam Tower
... líder mundial en servicios de envío, la empresa trabaja en 130 países y emplea aproximadamente a 70.000 personas. Con una oferta simple de productos y servicios digitales de un extremo a otro, un compromiso continuo con el cliente y una red de entrega magistral de un extremo a otro, Maersk ...
More »
Maersk Kanoo (Emirates)
13.07.2024
Maersk Trainee (UAE National)
United Arab Emirates, AEDXB12 - Dubai - Burj Al Salam Tower
We Offer An opportunity to work on transformational projects that are directly linked to our business strategy A mentor who will guide you along the way Opportunities to meet and learn from our senior leaders A chance to volunteer at our fun committees and Corporate Social Responsibility activities. ...
More »
Maersk Kanoo (Emirates)
13.10.2023
Regulatory Liaison Specialist - Vice President
United States of America, New York, 1 Columbus Circle
... Bank is the leading German bank with strong European roots and a global network. We’re driving growth through our strong client franchise. Against a backdrop of increasing globalization in the world economy, Deutsche Bank is very well-positioned, with significant regional diversification and ...
More »
0839 Deutsche Bank Aktiengesellschaft, Filiale New York
09.07.2023
chef de projet et coordonnateur du contenu graphique aux Affaires réglementaires / Regulatory Affairs Project Leader, Artwork Coordinator
Canada, Montreal Queen Street
... avons obtenu 13 approbations importantes. Nous avons plus que doublé le nombre de nouveaux vaccins et de médicaments en cours d’études cliniques de phase III, qui s’élèvent maintenant à 23 au total. Nos produits en développement, soit 21 vaccins et 43 médicaments, pourraient s’avérer être les ...
More »
837 GlaxoSmithKline Inc.